BackAura Biosciences Overview

Aura Biosciences Operating Income

Aura Biosciences's operating income is $-110M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-48069000.00
68% YoY

As of Jun 30, 2026

Annual Operating Income (TTM)

$-110172000.00
95.27% YoY

Trailing 12 months ending Jun 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Aura Biosciences (AURA) FAQ

Aura Biosciences (AURA) currently reports a operating income of $-110M as of June 2026. That compares with $-56M in the prior-year period — down 95.3% year over year. Use the charts on this page to explore Aura Biosciences's operating income history and peer comparisons.

Aura Biosciences's operating income decreased from $-56M to $-110M — a 95.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aura Biosciences reported $-110M in operating income as of June 2026. That compares with $-56M in the prior-year period — down 95.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aura Biosciences, and consider following AURA for alerts when major investors trade the stock.